JPMorgan Chase & Co’s NextCure NXTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $348 | Sell |
63
-4
| -6% | -$22 | ﹤0.01% | 5844 |
|
|
2025
Q1 | $387 | Hold |
67
| – | – | ﹤0.01% | 5845 |
|
|
2024
Q4 | $621 | Hold |
67
| – | – | ﹤0.01% | 5731 |
|
|
2024
Q3 | $1.11K | Hold |
67
| – | – | ﹤0.01% | 5646 |
|
|
2024
Q2 | $1.28K | Hold |
67
| – | – | ﹤0.01% | 5560 |
|
|
2024
Q1 | $1.79K | Sell |
67
-58
| -46% | -$1.55K | ﹤0.01% | 5575 |
|
|
2023
Q4 | $1.72K | Sell |
125
-121
| -49% | -$1.66K | ﹤0.01% | 5708 |
|
|
2023
Q3 | $3.8K | Buy |
246
+2
| +0.8% | +$31 | ﹤0.01% | 5474 |
|
|
2023
Q2 | $5.26K | Hold |
244
| – | – | ﹤0.01% | 5270 |
|
|
2023
Q1 | $4K | Hold |
244
| – | – | ﹤0.01% | 5432 |
|
|
2022
Q4 | $4K | Sell |
244
-182
| -43% | -$2.98K | ﹤0.01% | 5265 |
|
|
2022
Q3 | $14K | Sell |
426
-2,385
| -85% | -$78.4K | ﹤0.01% | 5006 |
|
|
2022
Q2 | $159K | Buy |
2,811
+1,320
| +89% | +$74.7K | ﹤0.01% | 4422 |
|
|
2022
Q1 | $87K | Buy |
1,491
+760
| +104% | +$44.3K | ﹤0.01% | 4807 |
|
|
2021
Q4 | $53K | Buy |
731
+526
| +257% | +$38.1K | ﹤0.01% | 5050 |
|
|
2021
Q3 | $17K | Sell |
205
-3,598
| -95% | -$298K | ﹤0.01% | 5167 |
|
|
2021
Q2 | $367K | Buy |
3,803
+708
| +23% | +$68.3K | ﹤0.01% | 4170 |
|
|
2021
Q1 | $372K | Buy |
3,095
+2,450
| +380% | +$294K | ﹤0.01% | 4196 |
|
|
2020
Q4 | $85K | Sell |
645
-9,987
| -94% | -$1.32M | ﹤0.01% | 4344 |
|
|
2020
Q3 | $1.09M | Buy |
10,632
+7,703
| +263% | +$788K | ﹤0.01% | 3059 |
|
|
2020
Q2 | $753K | Buy |
2,929
+2,543
| +659% | +$654K | ﹤0.01% | 3142 |
|
|
2020
Q1 | $172K | Sell |
386
-726
| -65% | -$324K | ﹤0.01% | 3760 |
|
|
2019
Q4 | $752K | Buy |
1,112
+1,030
| +1,256% | +$697K | ﹤0.01% | 3231 |
|
|
2019
Q3 | $30K | Sell |
82
-30
| -27% | -$11K | ﹤0.01% | 4398 |
|
|
2019
Q2 | $19K | Buy |
+112
| New | +$19K | ﹤0.01% | 4529 |
|